<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 19, 2000
MGI PHARMA, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Minnesota 0-10736 41-1364647
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission file number) (I.R.S. Employer
of incorporation) Identification No.)
6300 West Old Shakopee Road, Suite 110, Bloomington, MN 55438
-------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (952) 346-4700
--------------
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS
On July 19, 2000, MGI PHARMA, Inc. (the "Company") reported its
earnings for the second quarter of 2000 in a press release, which is filed as
Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS
99.1 Press Release, dated July 19, 2000.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
July 24, 2000 MGI PHARMA, INC.
By: /s/ William C. Brown
------------------------------
William C. Brown
Chief Financial Officer and Secretary
-3-
